PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 27498916-9 2016 The expression of Mac-1 and L-selectin decreased by 51.0% (P< .01) and 30.9% (P= .02), respectively, following face mask inhalation of budesonide and by 39.8% (P= .01) and 17.4% (P= .17), respectively, following inhalation of fluticasone. Budesonide 138-148 integrin subunit alpha M Homo sapiens 18-23 10837366-4 2000 Budesonide, hydrocortisone, and prednisolone, but not the sex steroids testosterone and progesterone, reduced CD11b and CD49d cell-surface expression to a similar extent. Budesonide 0-10 integrin subunit alpha M Homo sapiens 110-115 11029322-4 2000 We measured the modulation of expression of clonal designator (CD)11b and L-selectin with flow cytometry after 4 h or 16 h of culture of eosinophils when budesonide or formoterol was applied either directly to the eosinophils while they were stimulated with FCM (direct method) or when each drug was applied to lung fibroblasts from which conditioned medium was then administered to eosinophils (indirect method). Budesonide 154-164 integrin subunit alpha M Homo sapiens 63-69 11029322-5 2000 In the direct method, budesonide (10(-)(8) M) inhibited the modulation of CD11b (44 [25th to 75th percentiles: 26 to 66]% of control) and L-selectin (30 [-13 to 48]% of control) only after 16 h, and not after 4 h. Formoterol did not directly inhibit the modulation of eosinophil CD11b and L-selectin expression. Budesonide 22-32 integrin subunit alpha M Homo sapiens 74-79 11029322-5 2000 In the direct method, budesonide (10(-)(8) M) inhibited the modulation of CD11b (44 [25th to 75th percentiles: 26 to 66]% of control) and L-selectin (30 [-13 to 48]% of control) only after 16 h, and not after 4 h. Formoterol did not directly inhibit the modulation of eosinophil CD11b and L-selectin expression. Budesonide 22-32 integrin subunit alpha M Homo sapiens 279-284 11029322-6 2000 In the indirect method, both budesonide and formoterol inhibited lung fibroblast activation, resulting in diminished eosinophil activation after 4 h. Budesonide or formoterol at 10(-)(8) M inhibited upregulation of CD11b to 26 [15 to 40]% and 38 [23 to 46]%, respectively, and inhibited L-selectin shedding to 14 [-3 to 50]% and 27 [2 to 62]%, respectively, of control values. Budesonide 29-39 integrin subunit alpha M Homo sapiens 215-220 11029322-6 2000 In the indirect method, both budesonide and formoterol inhibited lung fibroblast activation, resulting in diminished eosinophil activation after 4 h. Budesonide or formoterol at 10(-)(8) M inhibited upregulation of CD11b to 26 [15 to 40]% and 38 [23 to 46]%, respectively, and inhibited L-selectin shedding to 14 [-3 to 50]% and 27 [2 to 62]%, respectively, of control values. Budesonide 150-160 integrin subunit alpha M Homo sapiens 215-220 10718988-6 2000 Preincubation of the cells with different concentrations of budesonide was also effective in down-regulating the C5a-induced ICAM-1 expression on HBECs and the ah-CD23 and GM-CSF-induced LFA-1 and Mac-1 expression on eosinophils. Budesonide 60-70 integrin subunit alpha M Homo sapiens 197-202 30236840-8 2018 Further, we show that the budesonide NS enema treated mice had a significantly reduced number of inflammatory macrophages and IL-beta producing CD11b + cells in colon tissue compared to untreated controls or mice treated with the budesonide MS enema. Budesonide 26-36 integrin subunit alpha M Homo sapiens 144-149 30236840-8 2018 Further, we show that the budesonide NS enema treated mice had a significantly reduced number of inflammatory macrophages and IL-beta producing CD11b + cells in colon tissue compared to untreated controls or mice treated with the budesonide MS enema. Budesonide 230-240 integrin subunit alpha M Homo sapiens 144-149